Description
PAPILOCARE
Vaginal Gel
Description
Gel for the prevention and adjuvant treatment of lesions caused by human papillomavirus (HPV).
Creates a defensive barrier that prevents the risk of HPV integration and the formation of new lesions. Adjuvant in the re-epithelialization of lesions already present. Stimulates regeneration of the vaginal microbiota.
Suitable for:
monitor and help re-epithelialize the cervical transformation zone to prevent the risk of HPV-induced lesions (LSIL);
adjuvant treatment of intraepithelial lesions caused by HPV;
repair and help re-epithelialize lesions of the cervico-vaginal mucosa;
treat dryness of the cervico-vaginal mucosa;
rebalance the vaginal microbiota;
improve vaginal health;
create conditions for rapid healing of lesions caused by rubbing due to burning or itching;
form a protective film that quickly reduces discomfort, creating the right conditions to promote the natural healing process.
Promotes sexual intercourse. Compatible with condom use.
Formula tested under gynecological control.
Fragrance Free. pH 5
How to use
The duration of treatment is 6 months, with the possibility of further extending the period based on the medical prescription. It is important to complete the entire treatment cycle to achieve the expected results. It is recommended to start treatment after the menstrual cycle.
First month: apply one cannula per day for 21 consecutive days, then suspend treatment for the following 7 days.
Subsequent months (second through sixth): Apply one cannula every other day for 21 days.
Apply Papilocare preferably before going to sleep.
Insert the cannula into the vagina and apply pressure to release its contents. Then remove the cannula from the vagina while keeping it pressed so that it does not re-aspirate the dispensed product.
Warnings
Keep out of reach of children. Consult your doctor if you are pregnant. Discard any cannulas that are open or broken. Discard the cannula once used. Do not reuse a used cannula or share it with other patients.
Do not use in case of known hypersensitivity to one of its components. If discomfort occurs after application, stop using the product and consult a doctor. There are no data available on the use of Papilocare together with vaginal contraceptives, so the use of Papilocare is not recommended for women who are using this type of contraceptive. If you are pregnant, consult your doctor before using Papilocare and use it under strict medical supervision.
Papilocare has a good safety profile and no serious adverse reactions have been observed. The only adverse reaction is post-application irritation.
Conservation
Store at temperatures between 2°C and 25°C.
Validity for intact package: 42 months.
Format
7 single-dose cannulas of 5 ml.
Cod. 010/057
Gel for the prevention and adjuvant treatment of lesions caused by human papillomavirus (HPV).
Creates a defensive barrier that prevents the risk of HPV integration and the formation of new lesions. Adjuvant in the re-epithelialization of lesions already present. Stimulates regeneration of the vaginal microbiota.
Suitable for:
monitor and help re-epithelialize the cervical transformation zone to prevent the risk of HPV-induced lesions (LSIL);
adjuvant treatment of intraepithelial lesions caused by HPV;
repair and help re-epithelialize lesions of the cervico-vaginal mucosa;
treat dryness of the cervico-vaginal mucosa;
rebalance the vaginal microbiota;
improve vaginal health;
create conditions for rapid healing of lesions caused by rubbing due to burning or itching;
form a protective film that quickly reduces discomfort, creating the right conditions to promote the natural healing process.
Promotes sexual intercourse. Compatible with condom use.
Formula tested under gynecological control.
Fragrance Free. pH 5
How to use
The duration of treatment is 6 months, with the possibility of further extending the period based on the medical prescription. It is important to complete the entire treatment cycle to achieve the expected results. It is recommended to start treatment after the menstrual cycle.
First month: apply one cannula per day for 21 consecutive days, then suspend treatment for the following 7 days.
Subsequent months (second through sixth): Apply one cannula every other day for 21 days.
Apply Papilocare preferably before going to sleep.
Insert the cannula into the vagina and apply pressure to release its contents. Then remove the cannula from the vagina while keeping it pressed so that it does not re-aspirate the dispensed product.
Warnings
Keep out of reach of children. Consult your doctor if you are pregnant. Discard any cannulas that are open or broken. Discard the cannula once used. Do not reuse a used cannula or share it with other patients.
Do not use in case of known hypersensitivity to one of its components. If discomfort occurs after application, stop using the product and consult a doctor. There are no data available on the use of Papilocare together with vaginal contraceptives, so the use of Papilocare is not recommended for women who are using this type of contraceptive. If you are pregnant, consult your doctor before using Papilocare and use it under strict medical supervision.
Papilocare has a good safety profile and no serious adverse reactions have been observed. The only adverse reaction is post-application irritation.
Conservation
Store at temperatures between 2°C and 25°C.
Validity for intact package: 42 months.
Format
7 single-dose cannulas of 5 ml.
Cod. 010/057
